Corrections: DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells(J. Immunol (2005) 175 (4416-4425) DOI:10.4049/jimmunol.175.7.4416);DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells

Journal of Immunology

Volumn 175, Issue 7, 2005, Pages 4416-4425

  Pellicci, Daniel G ^a   Hammond, Kirsten J L ^b   Coquet, Jonathan ^a   Kyparissoudis, Konstantinos ^a   Brooks, Andrew G ^a   Kedzierska, Katherine ^a   Keating, Rachael ^a   Turner, Stephen ^a   Berzins, Stuart ^a   Smyth, Mark J ^c   Godfrey, Dale I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; CD1D ANTIGEN; CYTOKINE; FLUOROCHROME; T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

EID: 25444439254     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.2400135     Document Type: Erratum

References (37)

1. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
2. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114: 1379-1388.
3. Wilson, S. B., and T. L. Delovitch. 2003. Janus-like role of regulatory iNKT cells in autoimmune disease and tumor immunity. Nat. Rev. Immunol. 3: 211-222.
4. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
5. Crowe, N. Y., A. P. Uldrich, K. Kyparissoudis, K. J. Hammond, Y. Hayakawa, S. Sidobre, R. Keating, M. Kronenberg, M. J. Smyth, and D. I. Godfrey. 2003. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J. Immunol. 171: 4020-4027.
6. Wilson, M. T., C. Johansson, D. Olivares-Villagomez, A. K. Singh, A. K. Stanic, C. R. Wang, S. Joyce, M. J. Wick, and L. Van Kaer. 2003. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. USA 100: 10913-10918.
7. Harada, M., K. Seino, H. Wakao, S. Sakata, Y. Ishizuka, T. Ito, S. Kojo, T. Nakayama, and M. Taniguchi. 2004. Down-regulation of the invariant Vα14 antigen receptor in NKT cells upon activation. Int. Immunol. 16: 241-247.
8. + T cells lose NK1.1 expression upon in vitro activation. J. Immunol. 158: 5112-5119.
9. Hayakawa, Y., S. P. Berzins, N. Y. Crowe, D. I. Godfrey, and M. J. Smyth. 2004. Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors. Nat. Immunol. 5: 590-596.
10. 2 integrin, very late antigen-2). J. Immunol. 167: 1141-1144.
11. -/- mice. J. Immunol. 157: 2366-2373.
12. + T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-γ upon primary TCR stimulation. J. Immunol. 162: 5156-5163.
13. + cells. J. Immunol. 160: 1158-1165.
14. + T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells. J. Immunol. 167: 2087-2096.
15. Vinay, D. S., B. K. Choi, J. S. Bae, W. Y. Kim, B. M. Gebhardt, and B. S. Kwon. 2004. CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses. J. Immunol. 173: 4218-4229.
16. Higuchi, M., D. F. Zeng, J. Shizuru, J: Gworek, S. Dejbakhsh-Jones, M. Taniguchi, and S. Strober. 2002. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J. Immunol. 169: 5564-5570.
17. Byrne, P., P. McGuirk, S. Todryk, and K. H. Mills. 2004. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur. J. Immunol. 34: 2579-2588.
18. Antunez, M. I., and R. L. Cardoni. 2004. Trypanosoma cruzi: the expansion of NK, T, and NKT cells in the experimental infection. Exp. Parasitol. 106: 85-94.
19. Osada, T., H. Nagawa, and Y. Shibata. 2004. Tumor-infiltrating effector cells of α-galactosylceramide-induced antitumor immunity in metastatic liver tumor. J. Immune Based Ther. Vaccines 2: 7.
20. Moodycliffe, A. M., D. Nghiem, G. Clydesdale, and S. E. Ullrich. 2000. Immune suppression and skin cancer development: regulation by NKT cells. Nat. Immunol. 1: 521-525.
21. + cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes. Bone Marrow Transplant. 35: 191-197.
22. Yang, Y., A. Ueno, M. Bao, Z. Wang, J. S. Im, S. Porcelli, and J. W. Yoon. 2003. Control of NKT cell differentiation by tissue-specific microenvironments. J. Immunol. 171: 5913-5920.
23. Eberl, G., R. Lees, S. T. Smiley, M. Taniguchi, M. J. Grusby, and H. R. MacDonald. 1999. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 162: 6410-6419.
24. Hammond, K. J. L., S. B. Pelikan, N. Y. Crowe, E. Randle-Barrett, T. Nakayama, M. Taniguchi, M. J. Smyth, I. R. van Driel, R. Scollay, A. G. Baxter, and D. I. Godfrey. 1999. NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 29: 3768-3781.
25. Hammond, K. J. L., D. G. Pellicci, L. D. Poulton, O. V. Naidenko, A. A. Scalzo, A. G. Baxter, and D. I. Godfrey. 2001. CD1d-restricted NKT cells: an interstrain comparison. J. Immunol. 167: 1164-1173.
26. + T cells in autoimmune diabetes. Nat. Immunol. 2: 1117-1125.
27. - NK-like cells in the thymus. Blood 97: 1765-1775.
28. + T cell subsets distinguished by function and T cell receptor type. Eur. J. Immunol. 34: 56-65.
29. Gadue, P., and P. L. Stein. 2002. NK T cell precursors exhibit differential cytokine regulation and require itk for efficient maturation. J. Immunol. 169: 2397-2406.
30. Gadue, P., L. Yin, S. Jain, and P. L. Stein. 2004. Restoration of NK T cell development in fyn-mutant mice by a TCR reveals a requirement for Fyn during early NK T cell ontogeny. J. Immunol. 172: 6093-6100.
31. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192: 741-754.
32. Kedzierska, K., S. J. Turner, and P. C. Doherty. 2004. Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Proc. Natl. Acad. Sci. USA 101: 4942-4947.
33. Kim, S., K. Iizuka, H. S. Kang, A. Dokun, A. R. French, S. Greco, and W. M. Yokoyama. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3: 523-528.
34. + CD1d-dependent precursor stage. J. Exp. Med. 195: 835-844.
35. + NKT cells to liver injury in Plasmodium berghei-parasitized erythrocyte-injected mice. Int. Immunol. 16: 787-798.
36. Karnbach, C., M. R. Daws, E. C. Niemi, and M. C. Nakamura. 2001. Immune rejection of a large sarcoma following cyclophosphamide and IL-12 treatment requires both NK and NK T cells and is associated with the induction of a novel NK T cell population. J. Immunol. 167: 2569-2576.
37. Treiner, E., L. Duban, S. Bahram, M. Radosavljevic, V. Wanner, F. Tilloy, P. Affaticati, S. Gilfillan, and O. Lantz. 2003. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422: 164-169.